Category: Marijuana

Minnesota Overhauls Cannabis Limits: New 2026 Omnibus Bill Raises mg Caps for Food and Beverage Products–Edibles to 200 mg per Package

May 20, 2026 | Cultivation, Edibles, Marijuana

Minnesota’s new 2026 Cannabis Omnibus Bill dramatically alters the state’s marketplace. By introducing a “Ratio Hemp-Infused Cannabis Product” category, the legislation effectively doubles individual serving limits to 10 mg of THC and quadruples retail packaging caps to 200 mg. Discover how these updated milligram caps, along with the newly established Cannabis Macrobusiness licenses and adjusted social equity funding rules, are reshaping the industry landscape for local hemp manufacturers and retailers.

Read More →

The “Great Green Shift”: Minnesota’s 2026 Cannabis Market after Rescheduling

April 24, 2026 | Edibles, Legalization, Marijuana, Research

Explore the pivotal, surprising shifts defining the Minnesota cannabis market in 2026. From the Office of Cannabis Management’s unified regulatory framework to massive federal tax savings sparked by medical marijuana’s Schedule III rescheduling, the state’s landscape is rapidly transforming. However, with a looming federal hemp ban threatening local craft breweries, stakes are incredibly high. Discover the top takeaways shaping Minnesota’s complex green rush right now.

Read More →

The Great Cannabis Split: 5 Surprising Realities of the 2026 Federal Reclassification

April 24, 2026 | Health, Legalization, Marijuana, Research

In April 2026, the DOJ enacted a tectonic shift by reclassifying medical marijuana to Schedule III. While this historic move validates cannabis’s medical utility and eliminates crippling Section 280E taxes for medical operators, recreational cannabis remains trapped in Schedule I. This unprecedented “partial rescheduling” creates a bizarre dual-status reality where the exact same plant is treated as both a recognized medicine and a prohibited narcotic, forcing businesses to navigate a highly complicated legal landscape

Read More →

March 2026: Navigating Marijuana Rescheduling Challenges

March 17, 2026 | Cultivation, Legalization, Marijuana

As of March 17, 2026, efforts to reschedule marijuana from Schedule I to III face substantial administrative challenges, with the Department of Justice (DOJ) missing key deadlines and the Drug Enforcement Administration (DEA) experiencing procedural stasis. Key stakeholders express skepticism about the government’s commitment to reform, particularly due to ongoing tax issues under Section 280E, which burdens cannabis businesses. Additionally, while some states refine their cannabis frameworks, federal reform remains uncertain, indicating a prolonged conflict between executive mandates and administrative realities.

Read More →

The Home Scientist Guide to the Ultimate Marijuana Brownie: A Fudgy, Delicious Delight

March 7, 2026 | Edibles, Marijuana, Research

Stop guessing and start engineering. Move beyond “brownies in a bag” with this professional-grade masterclass in cannabis confectionery. This comprehensive guide breaks down the high-stakes chemistry of decarboxylation, the bioavailability of MCT vs. butter, and the essential role of lecithin in preventing “edible roulette.” Featuring precision dosing formulas, terpene-pairing flavor profiles, and a protocol for the perfect fudgy texture, this is the definitive resource for transforming a standard dessert into a sophisticated, science-backed delivery system.

Read More →

Navigating Minnesota’s New Cannabis Regulations for 2026

February 10, 2026 | Legalization, Marijuana

In 2026, Minnesota officially transitions to a regulated adult-use cannabis market. With nearly 49 new non-tribal dispensaries, including the first municipal facility in Anoka, the landscape is rapidly evolving. Consumers now face strict regulations, including a significant March 31 licensing deadline for hemp products. While personal freedoms for cannabis use are robust, federal threats loom, particularly regarding a scheduled hemp ban. Overall, Minnesota achieves social equity, but market stability remains uncertain.

Read More →

2026 High Weekend: The Ultimate Guide to America’s Premier 4/20 Celebrations

February 9, 2026 | Legalization, Marijuana

Celebrating the landmark 2026 High Weekend, this comprehensive guide explores the evolution of 4/20 from niche rallies to a professionalized four-day tourism surge. From Denver’s iconic festivals to San Francisco’s curated “drop parties,” we break down the must-attend events, essential travel logistics, and the shifting legal landscape for enthusiasts and industry professionals alike.

Read More →

Marijuana Research: What Science Says

February 6, 2026 | Marijuana, Research

As the U.S. moves toward rescheduling, 2024 research reveals complex truths about cannabis. While daily use raises heart attack risks by 25%, new long-term studies show adult cognition remains resilient, challenging old assumptions. From the “entourage effect” in pain relief to high-potency risks for adolescents, explore the molecular breakthroughs and public health challenges defining the new era of legalization

Read More →

Cannabis Rescheduling: What Schedule III Really Means

February 6, 2026 | Legalization, Marijuana, Research

Executive Order 14370 accelerates cannabis rescheduling to Schedule III, marking a pivotal shift in federal drug policy. This move promises significant economic benefits for the cannabis industry, including tax relief and banking access, while opening doors for critical medical research. However, challenges persist regarding high-potency products, impaired driving, and the continued call for full federal decriminalization amidst evolving public health concerns.

Read More →